such as cholesterol, corticosteroids and fatty acids. The most important feature of the CYP enzymes is its unique role in the intra-cellular metabolism by incorporation of an oxygen atom stereo-specifi cally into inert chemical bonds [ 3 , 5 ] . Among CYPs, CYP2C subfamily represents an important group of isozymes for drug metabolism in human, as these constitute about 16 % of the total hepatic CYP complement, and is known to be responsible for the metabolism of roughly 15 % of drug oxidations. Human CYP2C9 is a major CYP enzyme involved in the metabolism of a wide range of therapeutic agents, including non-steroidal anti-infl ammatory drugs, oral anticoagulants and oral hypoglycemic agents [ 5 ] . CYP2C9 also contributes to the metabolism of fatty acids, prostanoids and steroid hormones. The rat forms of the human CYP2C9 equivalent CYP2C isoforms include CYP2C6 and CYP2C11, with CYP2C11 being a 77 % homologue of the human CYP2C9 and the more abundantly expressed CYP in rat [ 6 ] .
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Introduction

▼
Over the past decades, herbal medicines are increasingly used as they are usually assumed to be safe and harmless. The World Health Organization (WHO) has recently reported that approximately 30-50 % of total medicinal consumption in China is herbal preparation, whereas between 50-70 % of North Americans and Europeans have used herbal medicine at least once in their lives [ 1 , 2 ] . Herbal drug supplements have traditionally been used alone or in combination with prescribed drugs for the treatment of several medical illnesses [ 3 , 4 ] . Such combinations could be associated with alterations in the pharmacokinetics and/or pharmacodynamics of the drugs. The majorities of these interactions are thought to be metabolism-based and involves induction or inhibition of the cytochrome P450 (CYP) system in the liver and other important organs. The CYP enzymes are a super family of haem containing enzymes. In humans, CYP enzymes are important in the production of compounds Aim: Combined use of herbs and drugs may result in clinically important herb-drug interactions. The majorities of these interactions are thought to be metabolism-based and involve induction or inhibition of cytochrome P450 (CYP). The current study was designed to investigate the eff ect of some commonly used herbs on rat CYP2C11 gene expression and metabolic activity. Methods: Wistar rats were treated for 7 days with increasing doses of 3 herbs; Nigella sativa, Trigonella foenum-graecum, and Ferula asafoetida . Thereafter, CYP2C11 mRNA and protein levels were determined by real-time polymerase chain reaction (RT-PCR) and western blot analyses, respectively. In vitro metabolic activity of CYP2C11 was performed on rat hepatic microsomes using tolbutamide as specifi c substrate.
Results:
Our results showed that all the 3 herbs signifi cantly inhibited the mRNA and protein expression levels of CYP2C11 in a dose-dependent manner. Furthermore, the in vitro enzyme metabolic activity study showed a signifi cant decrease in the formation of 4-hyroxy-tolbutamide, a tolbutamide metabolite, at the higher doses. The inhibitory eff ects of the investigated herbs on rat CYP2C11 was in the order: Nigella Sativa > Trigonella foenum-graecum > Ferula asafoetida . Conclusions: The 3 herbs are strong inhibitor of CYP2C11 expression, which can lead to an undesirable pharmacological eff ect of clinically used CYP2C11 substrate drugs with a low therapeutic index.
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The majority of serious cases of drug interactions are as a result of the interference of the metabolic clearance of one drug by yet another co-administered drug, food or natural product. Gaining mechanistic knowledge towards such interactions has been accepted as an approach for avoiding adverse reactions. To date, researches regarding drug-herb interactions are limited mostly to case reports and a few systematic reviews [ 7 -9 ] . Herbal drug supplements in the world have traditionally been used alone or in combination with prescribed drugs for the treatment of several medical illnesses [ 4 ] . A number of herbal remedy-drug interactions have been reported [ 10 ] . For example, it has been reported that herbal medicine and supplements have diff erentially modulated the induction of experimental as well as human CYP [ 11 ] . Some of the recent investigations have suggested modulations of CYP-mediated drug elimination as a major mechanism responsible for such interactions [ 12 ] . As a consequence, concomitant administration of these herbal medicines and clinically used drugs very likely raises the potential for herbal-drug interactions via altering the activity of certain CYP enzymes which may lead to serious clinical consequences. Several herbs are commonly used in many Asian countries for a variety of health-related problems. For example, black seed, the dried ripe seed of Nigella sativa Linn. (Family; Ranunculaceae), is used as a folk medicine for the treatment of various ailments such as hypertension, diabetes, infl ammation, asthma and dyslipidemia [ 1 , 13 ] . The important chemical constituents in the herb include fi xed oil (30-33 %) and a volatile oil (0.43-0.72 %) wt/wt of the seeds weight which contains thymoquinone (18.4-24 %), p-cymene (31.7 %), and α-pinene (9.3 %) [ 13 , 14 ] . Fenugreek herb is the dried ripe seed of Trigonella foenum-graecum Linn. (Family Fabaceae), which is used in treating kidney diseases, cellulites, diabetes, and tuberculosis in addition to its hypolipidemic and anticoagulant activities [ 15 , 16 ] . The chemical constituents of fenugreek are alkaloids containing trigonelline (0.13 %), choline (0.05 %), gentianine, carpaine and saponine [ 17 ] . Asafoetida, the gum resin obtained from Ferula asafoetida Linn. (Family Umbelliferae), is commonly used as spices and condiments as well as treatment of various ailments such as antispasmodic, carminative, laxative, expectorant and vermifuge [ 18 ] . An analysis of asafoetida shows it consists of 40-64 % resinos materials composed of ferulic acid, umbel-liferone, asaresinotannols, and farnesiferols A, B, and C, in addition to volatile oils (3-17 %) [ 17 -19 ] . However, the in vivo eff ects of these herbal medicine to potentially modulate the expression of CYP2C11 level have not been investigated yet. Therefore, the objectives of the current study was to investigate the potential eff ects of 3 commonly used local herbal medicines, Nigella sativa, Trigonella foenum-graecum, and Ferula asafoetida , on the expression of CYP2C11 gene at the mRNA, protein, and metabolic activity levels in rat liver tissues.
Materials and Methods
▼
Materials
Protease inhibitor cocktail, tolbutamide (TB), and 4-hydroytolbutamide (4-OH-TB) were purchased from Sigma-Aldrich (St. Louis, MO). TRIzol reagent was purchased from Invitrogen Co. 
Herbal medicine preparation
Crude herbs Nigella sativa, Trigonella foenum-graecum and Ferula asafoetida were purchased from a well-known herbal medicine supplier (Bin-Menkash, Riyadh) and were authenticated by taxonomist, Department of Pharmacognosy College of Pharmacy, King Saud University. A voucher specimen was deposited at the Herbarium of the College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. The shade dried herbs were powdered and stored in dried sterile containers until use. The reported human doses for the selected herbs Nigella sativa, Trigonella foenum-graecum and Ferula asafoetida were approximately 3, 5, and 3 g/day respectively [ 19 -21 ] . The equivalent rat doses for investigated herbs were determined by using following equation [ 22 ] :
Where, Km for rat is 6 while Km for human is 37.
The equivalent rat doses of Nigella sativa, Trigonella foenumgraecum and Ferula asafoetida herbs were found to be around 300, 500, and 300 mg/kg, respectively. Accordingly, the dose ranges for each herb were as follows: Nigella sativa (50-400 mg/ kg), Trigonella foenum-graecum (25-600) and Ferula asafetida (50-450). The equivalent rat doses were selected on the basis of calculated human dose to rule out the percentage infl uence of active constituent within the herbs. The ranges of the above doses were selected in the current study on the basis of their eff ectiveness in modulating CYP2C11 activity in rats and are within the usual dose range used by humans.
Animal
Adult male Wistar albino rats, weighing 230-250 g, were maintained under standard laboratory conditions of a 12-h light/dark cycle at 25 °C ± 2 °C. The animals had free access to pulverized standard rat pellet diet with water ad libitum and fasted overnight prior to the experiments. 
Experimental design and treatments
Wistar albino rats, randomly assigned into 6 groups of 6 rats each for each herb, were treated by oral administration by gavage every day for 7 consecutive days with increasing doses of 3 herbs in normal saline as follows: Nigella sativa seed suspension (0, 50, 100, 200, 300, and 400 mg/kg), Trigonella foenum-graecum seed suspension (0, 75, 150, 300, 600, and 750 mg/kg), and Ferula asafoetida oleogum resin suspension (0, 50, 75, 150, 300, 450 mg/kg). These animal doses have been selected based the equivalent human doses using specifi c equation [ 22 ] . All rats were sacrifi ced on the day 8 th and liver tissues were dissected for the preparation of liver microsomes (used for the determination of CYP2C11 activity and protein expression) and homogenates (used for the determination of CYP2C11 mRNA expression levels).
RNA extraction and cDNA synthesis
The total cellular RNA from the liver tissues was isolated using TRIzol reagent (Invitrogen ® ) according to the manufacturer's instructions and quantifi ed by measuring the absorbance at 260 nm. RNA quality was determined by measuring the 260/280 ratio ( > 1.8). Thereafter, fi rst strand cDNA synthesis was performed using the High-Capacity cDNA reverse transcription kit (Applied Biosystems ® ), according to the manufacturer's instructions as described previously [ 23 ] . Briefl y, 1.5 μg of total RNA from each sample was added to a mixture of 2.0 μl of 10 × reverse transcriptase buff er, 0.8 μl of 25 × dNTP mix (100 mM), 2.0 μl of 10 × reverse transcriptase random primers, 1.0 μl of MultiScribe reverse transcriptase, and 3.2 μl of nuclease-free water. The fi nal reaction mixture was kept at 25 °C for 10 min, heated to 37 °C for 120 min, heated for 85 °C for 5 min, and fi nally cooled to 4 °C.
Quantifi cation of mRNA expression by Real-Time Polymerase Chain Reaction (RT-PCR)
Quantitative analysis of CYP2C11 mRNA expression was performed by RT-PCR by subjecting the resulting cDNA to PCR amplifi cation using 96-well optical reaction plates in the ABI Prism 7 500 System (Applied Biosystems ® ) [ 23 ] . The 25-μl reaction mixture contained 0.1 μl of 10 μM forward primer and 0.1 μl of 10 μM reverse primer (40 nM fi nal concentration of each primer), 12.5 μl of SYBR Green Universal Master mix, 11.05 μl of nuclease-free water, and 1.25 μl of cDNA sample. Rat primers for CYP2C11 (forward: CACCAGCTATCAGTGGATTTGG and reverse: GTCTGCCCTTTGCACAGGAA) and β-ACTIN (forward: CCAGAT-CATGTTTGAGACCTTCAA and reverse: GTGGTACGACCAGAG-GCATACA) were purchased from Integrated DNA technologies (IDT, Coralville, IA). The fold change in the level of these genes between treated and untreated rates were corrected by the levels of β-ACTIN. The RT-PCR data were analyzed using the relative gene expression (i. e., ΔΔ CT) method, as described and explained previously [ 24 ] . Briefl y, the data are presented as the fold change in gene expression normalized to the endogenous reference gene β-ACTIN and relative to a calibrator. The fold change in the level of CYP2C11 between treated and untreated cells, corrected by the level of β-ACTIN, was determined using the following equation: fold change = 2 − Δ(ΔCt) , where ΔCt = Ct (target) − Ct (β-actin) and Δ(ΔCt) = ΔCt (treated) − ΔCt (untreated) .
Microsomes preparation
Rat hepatic microsomes were prepared by diff erential centrifugation as described previously [ 24 ] . Briefl y, liver tissues (weighed 4-6 g) were chopped and fi nely crushed tissues were homogenized in 2 mL of homogenization buff er (0.05 M Tris HCl, 1.5 % KCl, and 1 mM EDTA, pH 7.2). The homogenate was centrifuged at 9 000 × g for 20 min at 4 °C. The supernatant was carefully transferred to clean ultra-centrifuge tubes and centrifuged at 100 000 × g for 1 h at 4 °C. The pellet was washed in 2 mL of 150 mM KCl and centrifuged again at 100 000 × g for 1 h at 4 °C. The pellet was resuspended in 1 ml storage buff er (0.05 M Tris HCl, and 1 mM EDTA, pH 7.2) containing 20 % glycerol, by manual homogenization. Microsomal suspensions were stored at − 80 °C until use. The protein concentrations were determined by Lowry assay [ 25 ] .
Western blot analysis
Western blot analysis was performed using a previously described method [ 26 ] . Briefl y, 25 μg of microsomal protein from each treatment group was separated by 10 % sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE), and then electrophoretically transferred to nitrocellulose membrane. Protein blots were then blocked overnight at 4 °C in blocking solution containing 0.15 M sodium chloride, 3 mM potassium chloride, 25 mM Tris-base (TBS), 5 % skim milk powder, 2 % bovine serum albumin, and 0.5 % Tween-20. After blocking, the blots were washed several times with TBSTween-20 before being incubated with a goat CYP2C11 polyclonal antibody for 2 h at room temperature in TBS solution containing 0.05 % (v/v) Tween-20 and 0.02 % sodium azide. Incubation with a peroxidase-conjugated rabbit anti-goat IgG secondary antibody was carried out in blocking solution for 1 h at room temperature. The bands were visualized using the enhanced chemiluminescence method according to the manufacturer's instructions, GE Healthcare Life Sciences (Pittsburgh, PA). The intensity of CYP2C11 protein bands was quantifi ed relative to the signals obtained for β-actin protein, using ImageJ 
Microsomal incubation conditions
Incubation conditions were selected based on previous study [ 27 ] . TB (5.0 μl of 15 mM to give a fi nal concentration of 0.15 mM) was added to the tubes before the addition of rat liver microsomes (0.25 mg protein/ml fi nal concentration) and potassium phosphate buff er (0.1 M, pH 7.4), then mixed gently, and preincubated in a shaker water bath at 37 °C for 30 min. The reaction was initiated by the addition of 25 μl of 20 mM NADPH (1.0 mM fi nal concentration) to complete a fi nal volume of 0.5 ml, and incubated for a further 30 min. Moreover, negative microsomal incubations were prepared without adding NADPH or without microsomes. The reaction was terminated by the addition of cold methanol (250 μl) with vigorous shaking for 2.0 min. Nitrazepam (25 μl) from a stock solution of 1.0 μg/ml was added as an internal standard to each tube. The mixture was centrifuged at 9 000 × g for 10 min; a 500 μl of the supernatant was transferred to HPLC autosampler vial and 50 μl of that was injected for analysis. Formation of the metabolite was found in the preliminary experiments to be linear with respect to time and protein concentration under the described conditions.
Analysis of 4-OH-TB in rat liver microsomes
The formation of 4-OH-TB in liver microsomes was analyzed using previously published HPLC methods with slight modifi cation [ 27 , 28 ] . A symmetry column (150 × 3.9 mm ID, 5.0 μm) purchased from Waters ® (Milford, MA) was used for this assay. 
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Mobile phase consisted of acetonitrile: 0.02 M potassium dihydrogen orthophosphate (25:75; pH adjusted to 3.4 with orthophosphoric acid). The fl ow rate was 1.5 ml/min. The detector was operated at fi xed wave length at 230 nm. Stock solutions of TB, and 4-OH-TB were prepared in acetonitrile and methanol; respectively. Calibration curve for 4-OH-TB was constructed using a concentration range of 0.05-2.5 μM. Each calibration curve was prepared to contain a fi xed concentration of TB (0.15 mM), microsomes and buff er but without the addition of NADPH.
Statistical analysis
The comparative analysis of the results from various experimental groups with their corresponding controls was performed using Sigma Stat ® for Windows (Systat Software, Inc, CA). Oneway analysis of variance (ANOVA) followed by Dunnett's test was carried out to assess which treatment groups showed a significant diff erence from the control group. The diff erences were considered signifi cant when p < 0.05.
Results
▼
Eff ect of herbs on the mRNA expression of CYP2C11
RT-PCR analysis demonstrated that all tested herbs signifi cantly down-regulated the mRNA expression of CYP2C11. For example, Nigella sativa at doses 100-400 mg/kg markedly and significantly inhibited CYP2C11 mRNA levels by approximately 83 % ( • ▶ Fig. 1a ). On the other hand, only higher doses of Trigonella 
Eff ect of herbs on the protein expression of CYP2C11
Western blot analysis showed that that CYP2C11 protein levels were signifi cantly down-regulated by all tested doses of Nigella sativa and Trigonella foenum-graecum herbs in a dose-dependent fashion, and only by the higher doses of Ferula asafetida , in a manner similar to the RNA results. For example, the highest doses of Nigella sativa, Trigonella foenum-graecum , and Ferula asafoetida inhibited CYP2C11 protein levels by approximately 90 %, 85 %, and 40 %, respectively ( • ▶ Fig. 2 ) .
Eff ect of herbs on the metabolic activity of CYP2C11
Eff ects of the herbs were evaluated based on the formation of CYP2C11-mediated 4-OH-TB from TB in rat liver microsomes. Our results showed that Nigella sativa, Trigonella foenum-graecum and Ferula asafoetida inhibited CYP2C11-mediated 4-OH-TB formation in a dose-dependent manner. Nigella sativa exhibited the maximum inhibitory eff ect on the CYP2C activity by approximately 53 % at the highest dose, 400 mg/kg ( • ▶ Fig. 3a ) .
Whereas, Trigonella foenum-graecum and Ferula asafoetida decreased CYP2C11 metabolic activity by approximately 43 % and 39 %, respectively at their highest doses ( • ▶ Fig. 3b, c ).
Discussion and Conclusions
▼
Traditional medicine has received great attention as an alternative clinical therapy because its therapeutic effi cacy is mild and broad, and the incidence of adverse reactions is relatively low in comparison with synthetic drugs. However, combined use of herbs and drugs may increase or reduce the eff ects of either component, which may result in clinically important herb-drug interactions [ 29 ] . Many herbs and natural compounds isolated from herbs have been identifi ed as inhibitors of CYP2C enzyme, and hence may interfere with drug metabolism causing drug-and food-drug in interactions and toxicities. CYP2C9 is one of the most abundant CYP enzymes in the human liver (20 % of hepatic total CYP content), where it metabolizes approximately 15 % clinical drugs (~4 100 drugs), including a number of drugs with narrow thera- peutic ranges [ 30 ] . Therefore, the induction or inhibition on activity of CYP2C9 may lead to some undesirable eff ects. For example, it has been suggested that the use Danshen, ( Salvia miltiorrhiza ), a popular traditional Chinese medicinal herb that used for the treatment of cardiovascular disease, with drugs that particularly metabolized by CYP2C, such as warfarin, should be monitored [ 31 ] . In addition, polysaccharide peptides from Coriolus versicolor are known to inhibit TB 4-hydroxylation in the rat in vitro and in vivo [ 6 ] .
Additionally, several studies have demonstrated pharmacokinetic interactions of herbs specifi cally Ferula asafoetida, Trigonella foenum-graecum, and Nigella sativa with drugs in animals models [ 32 -36 ] . Unfortunately, none of these studies have investigated the molecular mechanisms involved. Therefore, in the current study we have initially addressed the question of whether herbs are able to modulate the CYP2C11 at the gene expression. For this purpose, rats were pretreated with widerange doses of investigated herbs were analyzed hepatic CYP2C11 mRNA levels.
Our results show that all tested herbs signifi cantly down-regulated the mRNA expression of CYP2C11. Importantly, we have showed that the inhibitory eff ects of herbal medicine on CYP2C11 mRNA in herbs-treated rats is translated into a decrease in the protein function at the translational levels, we measured the CYP2C protein levels using Western blot analysis.
• ▶ Fig. 2 shows that CYP2C11 protein levels were signifi cantly down-regulated by all investigated herbs, Nigella sativa (90 % at 400 mg/kg), Trigonella foenum-graecum (80 % at 600 mg/kg), and Ferula asafoetida (40 % at 450 mg/kg) showed signifi cant inhibition of hepatic CYP2C11 protein expression in similar manner to the mRNA results. These results are in agreement with a previous study showed that Nigella sativa significantly inhibited CYP2C11 mRNA and protein levels in rats [ 2 ] . To further substantiate the inhibitory eff ect of the investigated herbs, we examined the eff ect on the CYP2C11 metabolic activity in rats liver microsomes. The most widely used substrate probes for determining CYP2C9 activity in liver microsomes are (S)-warfarin (7-hydroxylation), tolbutamide (methylhydroxylation), and diclofenac (4-hydroxylation). Among these substrates, CYP2C9 is essentially solely responsible for TB hydroxylation and thus TB is accepted widely as a prototypic substrate for the assessment of hepatic CYP2C9 activity, both in vitro and in vivo [ 30 ] . Therefore, we measured the catalytic activity of CYP2C11 by measuring the ability of herbs to decrease the hepatic microsomal formation of 4-OH-TB.
• ▶ Fig. 3 shows that incubation of liver microsomes obtained from Nigella sativa treated rats with TB signifi cantly decreased the formation of 4-OH-TB by all tested doses to a maximum inhibition of approximately 50 % at the highest doses. Likewise, Trigonella foenum-graecum and Ferula asafoetida inhibited the metabolite formation signifi cantly.
The results of the current study clearly explore the molecular (transcriptional and translational) mechanism of inhibition of CYP2C11 gene by the herbs. These fi ndings are in agreement with several previous studies demonstrated that Nigella sativa's main constituents thymoquinone inhibited CYP2C11 enzyme [ 2 ] . In addition, some fl avonoids in Trigonella foenum-graecum, such as vitexin, tricin, naringenin, quercetin and tricin-7-Obeta-D-glucopyranoside are known CYP inhibitors [ 37 -39 ] . Moreover, terpenoidal and ferulic acid compounds in Ferula asafoetida are CYP2C modulators [ 40 , 41 ] . Taken together, it could be postulated that herbs constituents act as competitive or noncompetitive inhibitors of CYP2C11, depending on whether they bind to the substrate binding site or an allosteric binding site of the enzyme and further studies are needed [ 42 ] .
In conclusion, the present work provided the fi rst evidence that 3 commonly used herb remedies Nigella sativa, Trigonella foenum-graecum and Ferula asafetida signifi cantly inhibited the expression of CYP2C11 gene at the mRNA, protein, and metabolic activity levels in rats liver and hence may increase the risk of toxicity from co-administered drugs that are CYP2C11 substrates with narrow therapeutic indices such as warfarin, TB, and phenytoin [ 39 ] .
